medigraphic.com
ISSN 1560-4381 (Print)

2020, Number 1

<< Back Next >>

Correo Científico Médico 2020; 24 (1)

Diagnosis, treatment and prevention of gout

Ludeña SMC, Marín FRE, Anchundia CEF, Villacrés MLF, Torres RMI

Language: Spanish
References: 42
Page:
PDF size: 495.14 Kb.


ABSTRACT

Gout is an inflammatory arthritis associated with hyperuricemia, it is characterized by the crystallization of monosodium urate in the joints and tissues. It produces a substantial morbidity due to pain in acute gouty arthritis and joint deformities in chronic tophaceous gout. It is linked to systemic diseases such as metabolic syndrome and diabetes. Environmental and genetic factors contribute to hyperuricemia. Gout is the result of an inflammatory response to the crystals and the treatment strategies that dissolve the crystals are crucial for its effective handling. Healthy dietary habits and serum uric acid reducing drugs can contribute to a better control of uricemia and diseases associated with gout. This review describes the diagnosis, treatment and prevention of gout.


REFERENCES

  1. Velasco Bustamante JA, Velasco Bustamante DL, Baquero Vallejo GA, Gomez Valverde JL, Villacres Pinza MA, Jinez Coca KA. Monoartritis aguda. Urgencia en la atención reumatológica. Rev Cubana Reumatol. 2019 [citado 02/10/ 2019]. Disponible en: http://www.revreumatologia.sld.cu/index.php/reumatologia/article/view/728

  2. Ragab G, Elshahaly M, Bardin T. Gout: An old disease in new perspective – A review. J Adv Res. 2017[citado 02/10/ 2019]; 8(5): 495–511. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512152/pdf/main.pdf

  3. Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hiperuricemia in the US general population: The National Health and Nutrition Examination Survey 2007–2008. Arthritis Rheum 2011[citado 02/10/ 2019]; 63(10):3136–3141. Disponible en: https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.30520

  4. Bardin T, Bouee S, Clerson P, Chales G, Doherty M, Flipo RM, et al. Prevalence of Gout in the Adult Population of France. Arthritis Care Res. 2016[citado 02/10/ 2019]; 68 (2): 261–266. Disponible en: https://doi.org/10.1002/acr.22660

  5. Kuo CF, Grainge MJ, Mallen C, Zhang W, Doherty M. Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study. Ann Rheum Dis. 2015[citado 02/10/ 2019]; 74(4):661–667. Disponible en: https://ard.bmj.com/content/annrheumdis/74/4/661.full.pdf

  6. Annemans L, Spaepen E, Gaskin M, Bonnemaire M, Malier V, Gilbert T, et al. Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005. Ann Rheum Dis. 2008[citado 02/10/ 2019]; 67(7):960–966. https://ard.bmj.com/content/annrheumdis/67/7/960.full.pdf

  7. Winnard D, Wright C, Jackson G, Gow P, Kerr A, McLachlan A, et al. Gout, diabetes and cardiovascular disease in the Aotearoa New Zealand adult population: co-prevalence and implications for clinical practice. N Z Med J. 2012[citado 02/10/ 2019]; 126(1368):53–64. Disponible en: https://www.nzma.org.nz/journal/read-the-journal/all-issues/2010-2019/2013/vol-126-no-1368/article-winnard

  8. Kuo CF, Grainge MJ, See LC, Yu KH, Luo SF, Zhang W, et al. Epidemiology and management of gout in Taiwan: a nationwide population study. Arthritis Res Ther. 2015[citado 02/10/ 2019]]; 17: 13. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342824/?report=reader

  9. Usenbo A, Kramer V, Young T, Musekiwa A. Prevalence of Arthritis in Africa: A Systematic Review and Meta-Analysis. PLoS One. 2015[citado 02/10/ 2019]; 10(8): 133858. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4524637/pdf/pone.0133858.pdf

  10. Robinson PC. Gout - An update of aetiology, genetics, co-morbidities and management. Maturitas. 2018[citado 2 oct 2019]; 118:67-73. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S0378512218305371

  11. Vizcaino Luna Y, Bermúdez Marrero WM, Bermúdez Marrero WA, Egües Mesa JL, Cárdenas Domínguez T, Prendes García E. Gout Arthritis. Ten years of follow up. Rev Cubana Reumatol. 2019 [citado 02/10/ 2019];21(3). Disponible en: http://www.revreumatologia.sld.cu/index.php/reumatologia/article/view/717

  12. Beyl RN Jr, Hughes L, Morgan S. Update on Importance of Diet in Gout. Am J Med. 2016[citado 02/10/ 2019]; 129(11):1153-1158. Disponible en: https://www.amjmed.com/article/S0002-9343(16)30723-9/pdf

  13. Schlienger JL. L’histoire des tourments de la podagre (goutte). Médec Malad Métabol. 2014[citado 02/10/ 2019]; 8(2):230-234. Disponible en: https://doi.org/10.1016/S1957-2557(14)70747-3

  14. Aurélien M, Boursier A, Brazier M, Fardellone P. Traitement de la goutte. En: Pharmacie Clinique et Thérapeutique.5Ta ed.Francia: Elsevier Masson SAS; 2018[citado 02/10/ 2019];[13p].Disponible en: https://doi.org/10.1016/B978-2-294-75077-9.00020-7

  15. Aggarwal R, Ringold S, Khanna D, Neogi T, Johnson SR, Miller A, et al. Distinctions between diagnostic and classification criteria? Arthritis Care Res (Hoboken).2015[citado 02/10/ 2019]; 67(7):891–897. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482786/pdf/nihms692971.pdf

  16. Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yu TF. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum. 1977[citado 02/10/ 2019]; 20(3):895–900. Disponible en: https://doi.org/10.1002/art.1780200320

  17. Neogi T, Jansen TL, Dalbeth N, Fransen J, Schumacher HR, Berendsen D, et al. 2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2015[citado 02/10/ 2019];74(10):1789-1798. Disponible en: https://ard.bmj.com/content/74/10/1789.long

  18. Pascual E, Sivera F, Andrés M. Synovial fluid analysis for crystals. Curr Opin Rheumatol. 2011[citado 02/10/ 2019]; 23 (2):161-9. Disponible en: https://journals.lww.com/co-rheumatology/Abstract/2011/03000/Synovial_fluid_analysis_for_crystals.7.aspx

  19. Lioté F, Bardin T. Traitement de la goutte. Revue du Rhumatisme. 2007[citado 02/10/ 2019]; 74(2007): 160–167. Disponible en: http://www.rhumatologie.asso.fr/05-bibliotheque/publications/pub-74-160-167.asp

  20. Vargas Santos AB, Neogi T. Management of Gout and Hyperuricemia in CKD. Am J Kidney Dis. 2017[citado 02/10/ 2019]; 70(3):422-439. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28456346

  21. Dalbeth N, Merriman TR, Stamp LK. Gout. Lancet. 2016[citado 02/10/ 2019]; 388(10055): 2039–2052. Disponible en: http://dx.doi.org/10.1016/S0140-6736(16)00346-9

  22. Roman YM. The Daniel K. Inouye College of Pharmacy Scripts: Perspectives on the Epidemiology of Gout and Hyperuricemia. Hawaii J Med Public Health. 2019[citado 02/10/ 2019]; 78(2):71-76. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369891

  23. Chen J, Wu M, Yang J, Wang J, Qiao Y, Li X. The Immunological Basis in the Pathogenesis of Gout. Iran J Immunol. 2017[citado 02/10/ 2019]; 14(2):90-98. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/28630380

  24. Jamnik J, Rehman S, Blanco Mejia S, de Souza RJ, Khan TA, Leiter LA, et al. Fructose intake and risk of gout and hyperuricemia: a systematic review and meta-analysis of prospective cohort studies. BMJ Open. 2016[citado 02/10/ 2019];6(10):013191. Disponible en: https://bmjopen.bmj.com/content/bmjopen/6/10/e013191.full.pdf

  25. Singh JA. Gout and comorbidity: a nominal group study of people with gout. Arthritis Res Ther. 2017[citado 02/10/ 2019];19(1):204. Disponible en: https://doi.org/10.1186/s13075-017-1416-8

  26. Rubio Pampín MM, Martínez Larrarte JP. Histopatología de la membrana sinovial en la artritis gotosa. Rev Cubana Reumatol. 2015 [citado 02/10/ 2019];17(2). Disponible en: http://www.revreumatologia.sld.cu/index.php/reumatologia/article/view/411

  27. Bernal JA, Quilis N, Andrés M, Sivera F, Pascual E. Gout: optimizing treatment to achieve a disease cure. Ther Adv Chronic Dis. 2016[citado 02/10/ 2019];7(2):135-144. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772341

  28. Lu S, Zhang Q, Zhou Y. Serum/Synovial Fluid Urate Ratio as an Indicator for Distinguishing Gouty Arthritis From Other Arthritides. Arch Rheumatol. 2018[citado 15/02/ 2019]; 34(2):220-224. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719586/pdf/ArchRheumatol-34-220.pdf

  29. Rodríguez Linares JE, del Castillo Pasos MH. Gota en imágenes. Rev Cubana Reumatol. 2015 [citado 08/11/ 2019];17(3). Disponible en: http://www.revreumatologia.sld.cu/index.php/reumatologia/article/view/435

  30. Terkeltaub R. What makes gouty inflammation so variable? BMC Med. 2017[citado 02/10/ 2019]; 15(1):158. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561591

  31. Christiansen SN, Østergaard M, Terslev L. Ultrasonography in gout: utility in diagnosis and monitoring. Clin Exp Rheumatol. 2018; 36 Suppl 114(5):61-67.

  32. Bongartz T, Glazebrook KN, Kavros SJ, Murthy NS, Merry SP, Franz WB 3rd, et al. Dual-energy CT for the diagnosis of gout: an accuracy and diagnostic yield study. Ann Rheum Dis. 2015[citado 02/10/ 2019]; 74(6):1072-1077. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431329

  33. Schlesinger N, Detry MA, Holland BK, Baker DG, Beutler AM, Rull M, et al. Local ice therapy during bouts of acute gouty arthritis. J Rheumatol. 2002[citado 02/10/ 2019]; 29 (2):331–334. http://www.jrheum.org/content/29/2/331

  34. Terkeltaub RA, Furst DE, Bennett K, Kook KA, Crockett RS, Davis MW. High versus low dosing of oral colchicine for early acute gout flare: Twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, paral lel-group, dose-comparison colchicine study. Arthritis Rheum. 2010[citado 02/10/ 2019]; 62(2):1060-1068. Disponible en: https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.27327

  35. Dalbeth N, Stamp LK, Merriman TR. The genetics of gout: towards personalised medicine? BMC Med. 2017[citado 02/10/2019];15(1):108. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5452604

  36. Noss MR, Aron Saguil A. Gout: Diagnosis and Management. Am Fam Physician. 2017[citado 02/10/2019];96(10):668-670. Disponible en: https://www.aafp.org/afp/2017/1115/p668.html

  37. Reach G. L’observance dans la goutte. Revue du Rhumati. 2011[citado 02/10/ 2019]; 78(4): 319-323. Disponible en: https://doi.org/10.1016/j.rhum.2010.11.003

  38. Rodríguez Graña T, Peña González M, Gómez Trujillo N, Santisteban Lozano Y, Hernández Tamayo M. Estrés oxidativo: genética, dieta y desarrollo de enfermedades. CCM. 2015[citado 02/10/ 2019]; 19(4). Disponible en: http://www.revcocmed.sld.cu/index.php/cocmed/article/view/2151

  39. Major TJ, Topless RK, Dalbeth N, Merriman TR. Evaluation of the diet wide contribution to serum urate levels: meta-analysis of population based cohorts. BMJ. 2018[citado 02/10/ 2019]; 363:k3951. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174725

  40. Álvarez Lario B, Alonso Valdivielso JL. Hiperuricemia y gota: el papel de la dieta. Nutr Hosp. 2014[citado 02/10/ 2019]; 29(4):760-770. Disponible en: www.aulamedica.es/nh/pdf/7196.pdf

  41. Hainer BL, Matheson E, Wilkes RT. Diagnosis, Treatment, and Prevention of Gout. Am Fam Physician. 2014[citado 02/10/ 2019]; 90(12):831-836. Disponible en: https://europepmc.org/abstract/med/25591183

  42. Nielsen SM, Zobbe K, Kristensen LE, Christensen R. Nutritional recommendations for gout: An update from clinical epidemiology. Autoimmun Rev. 2018[citado 2 oct 2019];17(11):1090-1096. Disponible en: https://www.sciencedirect.com/science/article/pii/S156899721830209X




2020     |     www.medigraphic.com